Please assess the completion status of the following clinical trial:

Trial Title: Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age 18-50y,~* BMI 18-27,~* caucasian origin,~* type 1 diabetes diagnosed between age 5 and age 40,~* no known diabetes complications or cardiovascular diseases,~* no medication known to influence glucose homeostasis,~* no pregnancy~Exclusion Criteria:~* diabetes complications,~* autonomous nerve dysfunction,~* anaemia,~* HbA1c \< 8.5% at screening,~* estimated by the investigator to be incapable of completing the trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- type 1 DM with betacell function: Liraglutide (Type: EXPERIMENTAL): None
- type 1 DM without betacell function: Liraglutide (Type: EXPERIMENTAL): None
- type 1 DM without betacell function: Insulin (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).